Emelie Wallin
Papers
5
Total Citations
202
H-Index
4
About
Emelie Wallin is a Swedish gynecologic oncology researcher whose work has significantly advanced understanding of surgical approaches to early-stage cervical cancer, with a particular focus on robot-assisted radical hysterectomy (RRH). Based at a tertiary referral center in Sweden, Wallin has made substantial contributions to evaluating the oncologic, functional, and economic outcomes of minimally invasive robotic surgery compared to traditional open approaches. Her most influential work, a nationwide population-based cohort study published in 2019 and garnering over 105 citations, demonstrated no survival difference between robotic and open radical hysterectomy — a critical finding that informed clinical decision-making during a period of intense scrutiny of minimally invasive techniques following the landmark LACC trial. Complementing this, her research into quality-of-life outcomes examined sexual, bladder, and bowel function following RRH, providing patients and clinicians with nuanced postoperative expectations. Notably, her 2020 study revealed that greater institutional surgical experience with RRH correlates with reduced recurrence rates, highlighting the importance of surgical volume in optimizing outcomes. Wallin's body of work collectively bridges surgical technique, patient-reported outcomes, and population-level oncologic data, making her a valuable voice in the ongoing evolution of cervical cancer surgical management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5